| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |